US2016296664A1PendingUtilityA1
Methods for host cell homing and dental pulp regeneration
Est. expiryApr 12, 2033(~6.8 yrs left)· nominal 20-yr term from priority
A61L 27/52A61L 2400/06A61L 27/225A61L 27/54A61L 27/26C12N 2533/50A61L 27/16A61L 27/58A61L 27/3834A61L 2430/12A61L 2300/64A61L 27/3865A61L 27/18C12N 5/0664A61L 2300/406A61L 27/48A61K 9/06A61K 35/28A61K 35/32A61K 9/0024A61L 2400/12A61L 27/3808
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Hydrogel-based scaffolds useful for promoting pulp cell growth and biosynthesis, regulating pulp cell migration and morphology, or both as well as methods for their production and use are provided.
Claims
exact text as granted — not AI-modified1 . A hydrogel-based scaffold for dental pulp formation, said scaffold comprising a biosynthetic hydrogel of polymer and fibrinogen, wherein fibrinogen is present at a concentration sufficient for promoting pulp cell growth and biosynthesis, regulating pulp cell migration and morphology, or both.
2 . The hydrogel-based scaffold of claim 1 wherein the polymer comprises polyethylene glycol.
3 . The hydrogel-based scaffold of claim 1 which comprises an intact fibrinogen or a fibrinogen fragment.
4 . The hydrogel-based scaffold of claim 2 further comprising 0 to 40 mg/ml PEG-diacrylate.
5 . The hydrogel-based scaffold of claim 4 comprising 10 to 20 mg/ml of PEG-diacrylate to form PEG-fibrinogen monomers.
6 . The hydrogel-based scaffold of claim 5 further comprising additional PEG-diacrylate from 1.7% to 3.2% w/v.
7 . The hydrogel-based scaffold of claim 1 which is injectable.
8 . (canceled)
9 . The hydrogel-based scaffold of claim 1 which solidifies in vivo.
10 . The hydrogel-based scaffold of claim 1 which solidifies in vivo with non-toxic components.
11 . The hydrogel-based scaffold of claim 1 wherein the fibrinogen concentration is at least 5 to 10 mg/ml.
12 . The hydrogel-based scaffold of claim 1 wherein the fibrinogen concentration is at least 8 mg/ml.
13 . (canceled)
14 . The hydrogel-based scaffold of claim 1 further comprising an antibiotic.
15 . The hydrogel-based scaffold of claim 1 further comprising stem cells for tooth pulp repair and regeneration and/or dental pulp cells and/or endothelial cells.
16 . A method of promoting pulp cell growth and biosynthesis in a hydrogel-based scaffold, said method comprising modulating fibrinogen concentration, crosslinker content and/or PEG-diacrylate:fibrinogen ratio in the hydrogel-based scaffold.
17 . The method of claim 16 wherein the fibrinogen concentration is increased to at least 5-10 mg/ml.
18 . The method of claim 16 wherein the fibrinogen concentration is increased to at least 8 mg/ml.
19 . (canceled)
20 . The method of claim 16 wherein additional PEG-diacrylate content is from 1.7% to 3.2% w/v.
21 . A method of regulating cell infiltration into, migration and morphology within a hydrogel-based scaffold, said method comprising modulating fibrinogen concentration, crosslinker content and/or PEG-diacrylate:fibrinogen ratio in the hydrogel-based scaffold.
22 . The method of claim 21 wherein the fibrinogen concentration is increased to at least 5-10 mg/ml.
23 . The method of claim 21 wherein the fibrinogen concentration is increased to at least 8 mg/ml.
24 . (canceled)
25 . The method of claim 21 wherein additional PEG-diacrylate content is from 1.7% to 3.2% w/v.
26 . An in vitro method for differentiation and expansion of stem tells into dental pulp cells, said method comprising culturing stem cells on the hydrogel-based scaffold of claim 1 .
27 . A method for promoting tooth vitality in a subject in need thereof, said method comprising injecting, implanting or molding the hydrogel-based scaffold of claim 1 into a tooth of the subject.
28 . (canceled)
29 . (canceled)
30 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.